# 2025-03062: Yet Another Pharma Firm Wants to Import Controlled Drugs

2025-03062, Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-02-26, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 28, 2025. Such persons may also file a written request for a hearing on the application on or before March 28, 2025. (as of 2026-09-25).

- Canonical: https://policyrisk.com/federal-register/2025-03062
- As of: 2026-09-25
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-03062
- Title: Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 10732
- Published: 2025-02-26
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 28, 2025. Such persons may also file a written request for a hearing on the application on or before March 28, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-25

## In one line

Yet Another Pharma Firm Wants to Import Controlled Drugs

## Summary

S&B Pharma LLC, also known as Norac Pharma, wants to become an official importer of certain controlled drugs. People and companies involved with these drugs can share their thoughts or ask for a hearing by March 28, 2025. This move could affect drug supply chains and requires careful review but doesn’t mention any costs yet.

## Abstract

S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-03062 on federalregister.gov](https://www.federalregister.gov/documents/2025/02/26/2025-03062/importer-of-controlled-substances-application-sandb-pharma-llc-dba-norac-pharma)
- [2025-03062 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-02-26/pdf/2025-03062.pdf)

## Related
- [Previous: 2025-03061, Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC](https://policyrisk.com/federal-register/2025-03061)
- [Next: 2025-03065, Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Notice of Filing of a P…](https://policyrisk.com/federal-register/2025-03065)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-03062 (as of 2026-09-25).
